Highlights and Quick Summary
- Income from Discontinued Operations for the quarter ending December 31, 2020 was $5.39 Million (a -24.45% decrease compared to previous quarter)
- Year-over-year quarterly Income from Discontinued Operations decreased by -92.95%
- Annual Income from Discontinued Operations for 2020 was $95.7 Million (a -2872.48% decrease from previous year)
- Annual Income from Discontinued Operations for 2019 was $-3.45 Million (a -Infinity% decrease from previous year)
- Twelve month Income from Discontinued Operations ending December 31, 2020 was $95.7 Million (a 7.94% increase compared to previous quarter)
- Twelve month trailing Income from Discontinued Operations increased by 30.87% year-over-year
Trailing Income from Discontinued Operations for the last four month:
| 31 Dec '20 | 30 Sep '20 | 30 Jun '20 | 31 Mar '20 |
|---|---|---|---|
| $95.7 Million | $88.7 Million | $80.8 Million | $73.1 Million |
Visit stockrow.com/ORGS
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Income from Discontinued Operations of Orgenesis Inc.
Most recent Income from Discontinued Operationsof ORGS including historical data for past 10 years.Interactive Chart of Income from Discontinued Operations of Orgenesis Inc.
Orgenesis Inc. Income from Discontinued Operations for the past 10 Years (both Annual and Quarterly)
(All values are in $ million)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2020 | $5.39 | $7.13 | $6.72 | $76.47 | $95.71 |
| 2019 | $-1.65 | $-0.73 | $-0.95 | $-0.12 | $-3.45 |
| 2017 | – | – | – | $0.0 | – |
| 2016 | – | – | $0.0 | $0.0 | – |
| 2012 | – | – | – | – | $0.0 |
Business Profile of Orgenesis Inc.
Sector: Healthcare
Industry: Biotechnology